Skip to content

Geron GERN Compensation and benefits

Compensation and benefits at other companies

Incyte logo
IncyteINCY
Arcus Biosciences logo
Arcus BiosciencesRCUS
Tango Therapeutics logo
Tango TherapeuticsTNGX
Eli Lilly logo
Eli LillyLLY
GRAIL, Inc. logo
GRAIL, Inc.GRAL

Other financials

Income statement

See full
Revenue$51.8M+30.9%
Operating income$158.0K+101%
Net income-$3.6M+81.6%
EPS (diluted)-$0.01+66.7%

Balance sheet

See full
Cash & equivalents$48.7M-12.2%
Total debt$134.0M+10.0%
Total equity$229.1M-14.6%
Total assets$534.1M-5.0%

Cash flow

See full
Operating cash flow-$62.9M-31.1%
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$878.88M-8.6%
Enterprise value$964.15M-6.2%
P/S4.7×-172×

Profitability

See full
Operating margin-705.5%-351pp
Net margin-682.5%-339pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-27.1%-7.8pp
Debt / equity0.6×+0.1×
Current ratio6.8×-1.1×

Where this comes from

Reported directly by Geron in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Geron’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Geron's compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Geron's compensation and benefits?
Geron (GERN) reported compensation and benefits of $9.49M in Q1 2026.
How has Geron's compensation and benefits changed year-over-year?
Geron's compensation and benefits decreased by 1.2% year-over-year, from $9.6M to $9.49M.
What is the long-term trend for Geron's compensation and benefits?
Over 5 years (2020 to 2025), Geron's compensation and benefits has grown at a 30.0% compound annual growth rate (CAGR), from $8.22M to $30.5M.